Today: 29 April 2026
Snap stock slips as investors weigh ‘Specs’ smart-glasses spinoff ahead of earnings
30 January 2026
1 min read

Snap stock slips as investors weigh ‘Specs’ smart-glasses spinoff ahead of earnings

New York, January 30, 2026, 11:29 EST — Regular session

  • Snap shares fell about 2% in late-morning trading after a weak prior session
  • The company this week carved out its smart-glasses effort into a new “Specs” unit
  • Investors are now looking to Feb. 4 results for details on spending and funding plans

Snap Inc shares fell 2.2% to $7.08 in late-morning New York trading on Friday, after ending the previous session at $7.24. The stock has traded between $7.05 and $7.26 so far on the day.

The decline comes as investors have been quick to sell parts of the tech sector in recent sessions after Microsoft’s earnings-driven slide rattled sentiment and pulled major indexes lower, even as pockets of megacap strength held up.

For Snap, attention has also been on its push into augmented reality (AR) hardware — technology that overlays digital images onto a user’s view of the real world. The Snapchat owner said it is creating an independent subsidiary called “Specs” for its smart-glasses business, in a move aimed at attracting minority outside investment and building out partnerships as it hires for roughly 100 roles globally. Snap has invested more than $3 billion over 11 years in the effort, CEO Evan Spiegel said previously, and IDC’s Francisco Jeronimo said success is likely to depend more on ecosystem integration and software value than “breakthrough hardware innovation.” Meta leads the smartglasses market with about 70% unit share, IDC data showed in the report, with Xiaomi and Huawei next. Reuters

In a separate statement, Snap said making Specs a wholly owned subsidiary should give the effort more operational focus and “capital flexibility,” including the potential for minority investment, while helping clarify valuation ahead of a public launch later this year. newsroom.snap.com

The bet matters because wearables can soak up cash before they generate it. Investors have been wary of long-dated hardware projects, especially when ad-driven companies are still trying to show steadier growth.

There is also a downside case: consumer smart glasses are still a niche product, and any misstep on supply chains or a slow app ecosystem could delay launches and push costs higher. Meta and other larger rivals can spend through lean periods.

Snap’s next major catalyst is close. The company has scheduled its fourth-quarter and full-year 2025 results for February 4, with a conference call set for 5:00 p.m. Eastern time.

Traders will be listening for signs of ad demand in early 2026, any shift in cost guidance, and whether Snap can line up outside funding for Specs without taking on terms that dilute shareholders.

Stock Market Today

  • Humana Stock Dips Over 2% Amid Profit Forecast Revision
    April 29, 2026, 9:26 AM EDT. Humana Inc. (HUM) stock dropped more than 2% premarket after the health insurer maintained its adjusted full-year profit forecast at $9 per share but lowered its nonadjusted earnings estimate to at least $8.36 from $8.89. The company reported a 23% rise in first-quarter revenue and adjusted earnings per share beating expectations. However, charges from a multiyear transformation program to realign costs and operations weighed on results. Rising medical and pharmaceutical expenses, coupled with tighter government rules on Medicare Advantage payments, have pressured the sector. Humana, a major Medicare Advantage provider, faces ongoing margin challenges. Year to date, Humana shares have fallen about 13% amid these industry headwinds.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Nvidia stock price slips before the bell as China weighs DeepSeek’s H200 chip buys
Previous Story

Nvidia stock price slips before the bell as China weighs DeepSeek’s H200 chip buys

AT&T stock price rises again: $45 billion return plan, fiber deals and what comes next
Next Story

AT&T stock price rises again: $45 billion return plan, fiber deals and what comes next

Go toTop